CDK5RAP3 and neoplasm: Similarly, because CDK5RAP3 deficiency could make tumors dependent on HR or SSA repair pathways, it is conceivable that inhibiting HR, SSA or both combined would also be synthetically lethal in tumor cells with low CDK5RAP3 expression.